Skip to main content
. 2011 Dec 1;106(1):77–84. doi: 10.1038/bjc.2011.527

Table 3. Pharmacokinetic parameters for entinostat in plasma after Cycle 1, day 1.

    Pharmacokinetic parametersa
Dose (mg m 2 ) Number of patients Tmax (h) Cmax (ng ml −1 ) Vz/F (l m 2 ) Cls/F (l h −1  m 2 ) T1/2 (h) AUC0−∝ (ng h ml −1 )
4 14 0.50 (0.23–1.50) 114.3±84.0 1368±435b 16.8±26.3b 129.7±88.5b 586.6±401.1b
5 4 0.25 (025–1.00) 109.0±66.0 1003±634 10.8±8.0 77.3±31.9 778.4±648.2
Total 18 0.42 (0.23–1.50)   1256±508c 14.9±22.0c 113.6±78.2c  

Abbreviations: AUC0−∝=area under the concentration-time curve from time 0 to infinity; Cls/F, Cmax=maximal plasma concentration; Tmax=time of the maximal plasma concentration; T1/2=terminal half-life; VzF=apparent volume of distribution.

a

Values are median (range) for Tmax and mean±s.d. for AUC0−∝, Cmax, T1/2, and Vz/F.

b

n=9.

c

n=13.